Detalles de la búsqueda
1.
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(6): 504-513, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379158
2.
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study.
Lancet
; 402(10400): 451-463, 2023 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37423228
3.
Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma.
Br J Cancer
; 125(10): 1365-1376, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34588615
4.
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Anticancer Drugs
; 32(1): 88-94, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33332891
5.
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
BMC Cancer
; 19(1): 165, 2019 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30791870
6.
Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.
Br J Cancer
; 118(5): 639-647, 2018 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381689
7.
Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.
J Peripher Nerv Syst
; 21(3): 134-41, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27282616
8.
Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications.
Mol Oncol
; 18(2): 453-470, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943164
9.
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.
J Clin Oncol
; : JCO2302166, 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38552197
10.
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
Clin Cancer Res
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630755
11.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol
; 13(3): 239-46, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22285168
12.
An eHealth ecosystem for stepped and early psychosocial care in advanced lung cancer: Rationale and protocol for a randomized control trial.
Internet Interv
; 32: 100620, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37273934
13.
Screening for epidermal growth factor receptor mutations in lung cancer.
N Engl J Med
; 361(10): 958-67, 2009 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-19692684
14.
Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program.
Oncotarget
; 13: 812-827, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35720977
15.
Induction treatment in patients with stage III non-small cell lung cancer.
Transl Lung Cancer Res
; 10(1): 539-554, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569335
16.
Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
JAMA Neurol
; 78(7): 864-873, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33720308
17.
Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification.
J Immunother Cancer
; 9(2)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33632900
18.
Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study.
Ann Transl Med
; 9(8): 648, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33987346
19.
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 5: 93-102, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994593
20.
Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.
Cancers (Basel)
; 13(16)2021 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439322